Form 8-K - Current report:
SEC Accession No. 0001104659-25-048608
Filing Date
2025-05-14
Accepted
2025-05-14 17:13:23
Documents
13
Period of Report
2025-05-14
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2515122d1_8k.htm   iXBRL 8-K 30793
  Complete submission text file 0001104659-25-048608.txt   202424

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA swtx-20240514.xsd EX-101.SCH 3029
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE swtx-20240514_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE swtx-20240514_pre.xml EX-101.PRE 22368
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2515122d1_8k_htm.xml XML 3571
Mailing Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902
Business Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902 203-883-9490
SpringWorks Therapeutics, Inc. (Filer) CIK: 0001773427 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39044 | Film No.: 25947053
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)